Research Topics
| Jan HarnekSummaryAffiliation: Lund University Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral RJan Harnek
Department of Coronary Heart Disease, Skane University Hospital, Lund, Sweden
JACC Cardiovasc Interv 4:115-22. 2011..This study sought to assess the safety and efficacy of transcatheter valve annuloplasty in patients with mitral regurgitation (MR)...
Mild hypothermia reduces cardiac post-ischemic reactive hyperemiaGoran K Olivecrona
Department of Cardiology, Lund University, Lund, Sweden
BMC Cardiovasc Disord 7:5. 2007..Reperfusion results in a massive increase in blood flow, reactive hyperemia, which may contribute to reperfusion damage. We postulated that hypothermia could attenuate the post-ischemic reactive hyperemia...
Insertion of self-expandable nitinol stents without previous balloon angioplasty reduces restenosis compared with PTA prior to stentingJan Harnek
Heart Lung Division, University Hospital, Lund, Sweden
Cardiovasc Intervent Radiol 25:430-6. 2002..To compare the development of intimal hyperplasia after deployment of a self-expanding nitinol stent with and without previous percutaneous transluminal balloon angioplasty (PTA), with the results after PTA alone...
No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarctionKarin Astrom Olsson
Department of Cardiology, University Hospital, Lund, Sweden
Scand Cardiovasc J 36:237-40. 2002..The aim of this study was to investigate whether plasma MDA levels also increase after successful primary percutaneous transluminal coronary angioplasty (PTCA) in acute myocardial infarction (AMI)...
